Inflammatory Mechanism and Clinical Implication of Asthma in COVID-19
- PMID: 34594145
- PMCID: PMC8477697
- DOI: 10.1177/11795484211042711
Inflammatory Mechanism and Clinical Implication of Asthma in COVID-19
Abstract
Asthma is a chronic inflammatory disease of the respiratory tract that has become a public health problem in various countries. Referring to the Global Initiative for Asthma, the prevalence of asthma continues to increase especially in children. Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that has declared a pandemic by the world health organization on March 2020. For many years, it has been known that people with asthma have a worse impact on respiratory viral infections. Asthma has been listed by the centers for disease control and prevention as one of the risk factors for COVID-19, although several studies have different results. SARS-CoV-2 utilizes angiotensin-converting enzyme 2 (ACE2) as its cellular receptor, and it has been known that the expression of the ACE2 receptor is reduced in asthma patients. This reduced expression could also be accounted from the therapy of asthma. This paper aims to discuss the pathophysiology of asthma and COVID-19 and the susceptibility of asthma patients in contracting COVID-19.
Keywords: ACE2; Asthma; COVID-19.
© The Author(s) 2021.
Conflict of interest statement
Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699. Curr Opin Allergy Clin Immunol. 2021. PMID: 33186186 Review.
-
Putative mechanism of neurological damage in COVID-19 infection.Acta Neurobiol Exp (Wars). 2021;81(1):69-79. doi: 10.21307/ane-2021-008. Acta Neurobiol Exp (Wars). 2021. PMID: 33949163 Review.
-
COVID-19 and bronchial asthma: current perspectives.Glob Health Med. 2021 Apr 30;3(2):67-72. doi: 10.35772/ghm.2020.01117. Glob Health Med. 2021. PMID: 33937568 Free PMC article. Review.
-
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555. Elife. 2020. PMID: 32338605 Free PMC article.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
Cited by
-
Effect of Preexisting Asthma on the Risk of ICU Admission, Intubation, and Death from COVID-19: A Systematic Review and Meta-Analysis.Interdiscip Perspect Infect Dis. 2022 Jun 6;2022:8508489. doi: 10.1155/2022/8508489. eCollection 2022. Interdiscip Perspect Infect Dis. 2022. PMID: 35677466 Free PMC article. Review.
References
-
- Perhimpunan Dokter Paru Indonesia. Asma. 2018.
-
- Pynn MC, Thornton CA, Davies GA. Asthma pathogenesis. Pulmão RJ. 2011;21(2):11-17.
-
- GINA GI for A. Global Strategy for Ashtma Management and Prevention. Update 2020. 2020.
-
- Amin M. Asma bronkial. In: Buku Ajar Ilmu Penyakit Paru. Departemen Pulmonologi dan Ilmu Kedokteran Respirasi, FK Unair-RSUD dr Soetomo Surabaya; 2010:219.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous